Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution

被引:332
作者
Serhan, CN
机构
[1] Brigham & Womens Hosp, Dept Anesthesia Perioperat & Pain Med, Ctr Expt Therapeut & Reperfus Injury, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA 02115 USA
来源
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS | 2005年 / 73卷 / 3-4期
关键词
D O I
10.1016/j.plefa.2005.05.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lipoxins (LXs) or the lipoxygenase interaction products are generated from arachidonic acid via sequential actions of lipoxygenases and subsequent reactions to give specific trihydroxytetraene-containing eicosanoids. These unique structures are formed during cell-cell interactions and appear to act at both temporal and spatially distinct sites from other eicosanoids produced during the course of inflammatory responses and to Stimulate natural resolution. Lipoxin A(4) (LXA(4)) and lipoxin B-4 (LXB4) are positional isomers that each possesses potent cellular and in vivo actions. These LX structures are conserved across species. The results of numerous studies reviewed in this work now confirm that they are the first recognized eicosanoid chemical mediators that display both potent anti-inflammatory and pro-resolving actions in vivo in disease models that include rabbit, rat, and mouse systems. LXs act at specific GPCRs as agonists to regulate Cellular responses of interest in inflammation and resolution. Aspirin has a direct impact in the LX circuit by triggering the biosynthesis of endogenous epimers of LX, termed the aspirin-triggered 15-epi-LX, that share the potent anti-inflammatory actions of LX. Stable analogs of LXA(4), LXB4, and aspirin -triggered lipoxin were prepared, and several of these display potent actions in vitro and in vivo. The results reviewed herein implicate a role of LX and their analogs in many common human diseases including airway inflammation, asthma, arthritis, cardiovascular disorders, gastrointestinal disease, periodontal disease, kidney diseases and. graft-vs.-host disease, as well as others where uncontrolled inflammation plays a key role in disease pathogenesis. Hence, the LX pathways and mechanisms reviewed to date in this work provide a basis for new approaches to treatment of many common human diseases that involve inflammation. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:141 / 162
页数:22
相关论文
共 194 条
[1]   Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity [J].
Aliberti, J ;
Hieny, S ;
Sousa, CRE ;
Serhan, CN ;
Sher, A .
NATURE IMMUNOLOGY, 2002, 3 (01) :76-82
[2]   T(H)2 AND T(H)2-LIKE CELLS IN ALLERGY AND ASTHMA - PHARMACOLOGICAL PERSPECTIVES [J].
ANDERSON, GP ;
COYLE, AJ .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1994, 15 (09) :324-332
[3]   Aspirin-triggered lipoxin A4 and B4 analogs block extracellular signal-regulated kinase-dependent TNF-α secretion from human T cells [J].
Ariel, A ;
Chiang, N ;
Arita, M ;
Petasis, NA ;
Serhan, CN .
JOURNAL OF IMMUNOLOGY, 2003, 170 (12) :6266-6272
[4]   Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis [J].
Arita, M ;
Yoshida, M ;
Hong, S ;
Tjonahen, E ;
Glickman, JN ;
Petasis, NA ;
Blumberg, RS ;
Serhan, CN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (21) :7671-7676
[5]   LIPOXIN-A4 ANTAGONIZES CELLULAR AND INVIVO ACTIONS OF LEUKOTRIENE-D4 IN RAT GLOMERULAR MESANGIAL CELLS - EVIDENCE FOR COMPETITION AT A COMMON RECEPTOR [J].
BADR, KF ;
DEBOER, DK ;
SCHWARTZBERG, M ;
SERHAN, CN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (09) :3438-3442
[6]   Cyclooxygenase-2-derived prostaglandin E2 and lipoxin A4 accelerate resolution of allergic edema in Angiostrongylus costaricensis-infected rats:: Relationship with concurrent eosinophilia [J].
Bandeira-Melo, C ;
Serra, MF ;
Diaz, BL ;
Cordeiro, RSB ;
Silva, PMR ;
Lenzi, HL ;
Bakhle, YS ;
Serhan, CN ;
Martins, MA .
JOURNAL OF IMMUNOLOGY, 2000, 164 (02) :1029-1036
[7]   Cutting edge:: Lipoxin (LX) A4 and aspirin-triggered 15-Epi-LXA4 block allergen-induced eosinophil trafficking [J].
Bandeira-Melo, C ;
Bozza, PT ;
Diaz, BL ;
Cordeiro, RSB ;
Jose, PJ ;
Martins, MA ;
Serhan, CN .
JOURNAL OF IMMUNOLOGY, 2000, 164 (05) :2267-2271
[8]   Lipoxins and novel 15-epi-lipoxin analogs display potent anti-inflammatory actions after oral administration [J].
Bannenberg, G ;
Moussignac, RL ;
Gronert, K ;
Devchand, PR ;
Schmidt, BA ;
Guilford, WJ ;
Bauman, JG ;
Subramanyam, B ;
Perez, HD ;
Parkinson, JF ;
Serhan, CN .
BRITISH JOURNAL OF PHARMACOLOGY, 2004, 143 (01) :43-52
[9]   Molecular circuits of resolution: Formation and actions of resolvins and protectins [J].
Bannenberg, GL ;
Chiang, N ;
Ariel, A ;
Arita, M ;
Tjonahen, E ;
Gotlinger, KH ;
Hong, S ;
Serhan, CN .
JOURNAL OF IMMUNOLOGY, 2005, 174 (07) :4345-4355
[10]   Exogenous pathogen and plant 15-lipoxygenase initiate endogenous lipoxin A4 biosynthesis [J].
Bannenberg, GL ;
Aliberti, J ;
Hong, S ;
Sher, A ;
Serhan, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (04) :515-523